𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers

✍ Scribed by L. Cominacini; M. M. R. Young; A. Capriati; U. Garbin; A. Fratta Pasini; M. Campagnola; A. Davoli; A. Rigoni; G. B. Contessi; V. Lo Cascio


Book ID
105821820
Publisher
Springer
Year
1997
Tongue
English
Weight
95 KB
Volume
40
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Autoantibodies to oxidized low density l
✍ Griffin, M.E.; McInerney, D.; Fraser, A.; Johnson, A.H.; Collins, P.B.; Owens, D πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

Autoantibodies to oxidized low density lipoprotein have been shown to be an independent predictor of the progression of carotid atherosclerosis. This study examines the relationship between low density lipoprotein fatty acid composition and autoantibodies to both malondialdehyde-modified and copper-

Increased susceptibility to oxidation of
✍ K. Richard Bruckdorfer; Janet B. Hillary; Tim Bunce; Rama Vancheeswaran; Carol M πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 776 KB

Objective. To examine the resistance to oxidation of low-density lipoproteins (LDL) from patients with systemic sclerosis (SSc) and primary Raynaud's phenomenon (RP) compared with healthy controls. Methods. Plasma LDL were isolated from patients with diffuse cutaneous and limited cutaneous SSc (dcS

Cholesteryl-ester transfer protein enhan
✍ David Hine; Bharti Mackness; Mike Mackness πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 93 KB

Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to